International Clinical Trial: Induction Chemoimmunotherapy Followed by Concurrent Radiotherapy and Nimotuzumab in Elderly Patients (>60 Years) with Locally Advanced Nasopharyngeal Carcinoma: A Single-Arm, Phase II Clinical Study

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121720) titled 'Induction Chemoimmunotherapy Followed by Concurrent Radiotherapy and Nimotuzumab in Elderly Patients (>60 Years) with Locally Advanced Nasopharyngeal Carcinoma: A Single-Arm, Phase II Clinical Study' on April 2.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture

Condition: Nasopharyngeal Carcinoma

Intervention: Experimental group:1.Induction chemotherapy combined with immunotherapy:Sintilimab 200 mg intravenous infusion (ivgtt) on day 0, plus Gemcitabine 1000 mg/m^2 intravenous infusion (ivgtt) on days 1 and 8, p...